跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
合普卡 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Barnidipine Hydrochloride Sustained-release Capsules
Approved
化学药品
Barnidipine Hydrochloride Sustained-release Capsules
LTL PHARMA CO., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Dec 1, 2020
Approval ID
8DqlX8a2kQv
Company
LTL PHARMA CO., LTD.
Type
化学药品
Approval Details
Approval Id
8DqlX8a2kQv
Approval Number
国药准字HJ20140493
Generic Name
盐酸巴尼地平缓释胶囊
Generic Name En
Barnidipine Hydrochloride Sustained-release Capsules
Trade Name
合普卡
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
15mg
Reg Date
2020-12-01
Expired Date
2025-11-30
Company Name
LTL PHARMA CO., LTD.
Company Address
Nittochi Nishi-shinjuku Bldg 13F, 6-10-1, Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
Production Company Name
cmic cmo co., ltd. nishine plant
Production Company Address
154-13, Dai 2 Chiwari, Obuke, Hachimantai-shi, Iwate 028-7111, Japan
Company Detail Path
/organization/ltl-pharma-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 1, 2020
Approval ID
8DqlX8a2kQv
Type
化学药品
Back to NMPA Approvals